Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934876 · ClinicalTrials.gov registry record
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
A clinical trial of Acute Respiratory Failure, sponsored by Brian Driver.
- Recruiting
- Registry status
- 1,332
- Enrollment target
- 6
- Study locations
NCT06934876: Recruiting study of Acute Respiratory Failure, sponsored by Brian Driver.
NCT06934876 is a study of Acute Respiratory Failure that is actively recruiting participants, run by Brian Driver. The registered enrollment target is 1,332 participants, roughly in line with the 1,379-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target. The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934876, a study of Acute Respiratory Failure, is actively recruiting participants, sponsored by Brian Driver.
- RECRUITING
- Registry status
- 1,332 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation of critically ill adults.
Primary Outcome
The primary endpoint is the sensitivity of each test (against the reference standard) to accurately detect the tube location within the trachea. The sensitivity of each CO2 detection method describes the probability that the CO2 detection method is consistent with a tube location in the trachea for a patient who has an endotracheal tube located inside the trachea.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Colorimetric carbon dioxide (CO2) detection
- DIAGNOSTIC_TEST Waveform capnography
Study Locations (6)
North Carolina
- Duke University School of Medicine - Durham
- Wake Forest School of Medicine - Winston-Salem
Massachusetts
- Lahey Hospital & Medical Center - Burlington
Minnesota
- Hennepin Healthcare - Minneapolis
Ohio
- The Ohio State University College of Medicine - Columbus
Oregon
- Oregon Health and Sciences University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,332 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2027-01-01 |
What NCT06934876 shows while recruiting
NCT06934876 is an observational study that tracks outcomes without assigning an intervention. Its 1,332 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,379-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target.
The record links to 1 condition, with Acute Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Colorimetric carbon dioxide (CO2) detection is the first listed.
NCT06934876 lists 6 locations in 5 states (North Carolina, Massachusetts, Minnesota).
Frequently Asked Questions
What is clinical trial NCT06934876 about?
NCT06934876 is a clinical study titled "Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults". This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation of critically ill adults.
What is the current status of trial NCT06934876?
This trial is currently recruiting. The enrollment target is 1,332 participants. The study started on 2025-04-21. Estimated completion is 2027-01-01.
What conditions does trial NCT06934876 study?
This clinical trial studies the following conditions: Acute Respiratory Failure.
What interventions are being tested in trial NCT06934876?
The interventions under investigation include: Colorimetric carbon dioxide (CO2) detection (DIAGNOSTIC_TEST), Waveform capnography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06934876?
This trial is sponsored by Brian Driver, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934876 being conducted?
This trial has 6 study locations across Massachusetts, Minnesota, North Carolina, Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06934876's enrollment target sits among peer trials
1,332 3rd of 13 higher than 11 of 13 other Acute Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
RECRUITING
-
Investigating Dyadic Expectations About ARF Survivorship (IDEAS)
RECRUITING
-
Virtual Reality in ICU - PARTNER
RECRUITING
-
The Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial
ACTIVE NOT RECRUITING · NA
-
Treatment of Critical Illness Polyneuromyopathy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI